首都医科大学附属北京安贞医院科室详情

首都医科大学附属北京安贞医院介入诊疗科于2013年4月1日正式成立。介入诊疗科的前身为安贞医院导管室，其成立于1984年，是我国成立较早和完成心血管介入诊断与治疗例数最多的导管室之一。科室现有医生8人，护士32人、医学技术人员15人，其中主任医师2名，副主任医师2名;中级职称以上20人。科室目前有博士2人，硕士2人，本科学历20余人。现有三个导管区，大型血管造影机12台，血管内超声机(IVUS)4台，光学相干断层扫描成像系统(OCT)2台，血流储备分数检测仪(FFR)2台。科室为全院心血管造影及介入提供平台的同时，也独立或与其他科室合作完成各种心血管疾病造影检查和介入治疗。本着大综合，强专科的办院理念，介入诊疗科以心血管病介入治疗为主，兼顾非血管病介入治疗。目前除开展各种心血管造影检查外，重点开展成人先心病介入治疗，包括房间隔缺损封堵…

科室特色：科室在黄连军主任的带领下积极探索，勇攀高峰，开展了多项高难度、国内甚至是国际领先的介入技术：国内首先开展了主动脉缩窄合并症的腔内治疗，避免了传统外科手术带来的创伤，取得了满意的疗效;在国内首先开展了腹主动脉瘤腔内治疗中的“反向烟囱”技术，该项技术明显减少了术后并发症，提高了腹主动脉瘤患者术后的生活质量;在国内较早开展了“开窗”支架治疗腹主动脉瘤技术，良好的治疗效果也令患者和国内同行们推崇备至;胸主动脉疾病杂交技术的开展也实现了复杂疾病治疗简单化的目标，该技术同传统开刀手术相比，做到了减少了手术时间、失血量、住院时间及术后并发症。Under the leadership of director Huang Lianjun, our department vigorously explores and climbs to new heights boldly , carrying out several highly-difficult interventional technologies, which are leading both at home and abroad. The technologies include the initial intracavitary therapy of aortic coarctation complication in China, which avoided trauma from traditional surgical operation and obtained satisfying curative effect; the initially launched reversed chimney technique in intracavitary treatments of abdominal aortic aneurysm, which obviously reduced chances of complications and advanced life quality of patients postoperatively; and the stent fenestration in our hospital for treatment of this disease was an earlier domestic implementation, of which the favorable effects were admired and praised by patients and peers at home. In addition, the hybridization for thoracic aortic aneurysm has realized the aim for simplification in complex diseases treatments, the technology, when compared with traditional operation, may reduce operation duration, bleeding volume, length of stay as well as chances of postoperative complications.

首都医科大学附属北京安贞医院介入诊疗科于2013年4月1日正式成立。介入诊疗科的前身为安贞医院导管室，其成立于1984年，是我国成立较早和完成心血管介入诊断与治疗例数最多的导管室之一。科室现有医生8人，护士32人、医学技术人员15人，其中主任医师2名，副主任医师2名;中级职称以上20人。科室目前有博士2人，硕士2人，本科学历20余人。现有三个导管区，大型血管造影机12台，血管内超声机(IVUS)4台，光学相干断层扫描成像系统(OCT)2台，血流储备分数检测仪(FFR)2台。科室为全院心血管造影及介入提供平台的同时，也独立或与其他科室合作完成各种心血管疾病造影检查和介入治疗。

本着大综合，强专科的办院理念，介入诊疗科以心血管病介入治疗为主，兼顾非血管病介入治疗。目前除开展各种心血管造影检查外，重点开展成人先心病介入治疗，包括房间隔缺损封堵术，动脉导管未闭封堵术，室间隔缺损封堵术等;瓣膜病介入治疗包括主动脉瓣狭窄球囊成形术，肺动脉瓣狭窄球囊成形术，二尖瓣狭窄球囊成形术;主动脉及周围血管介入治疗，包括主动脉夹层，壁间血肿、溃疡、大动脉炎腔内修复术，主动脉假性动脉瘤，胸、腹主动脉瘤的腔内修复术：复杂胸腹主动脉瘤复合手术治疗等;还包括呼吸系统、消化道及妇科出血的栓塞治疗，恶性肿瘤化疗及栓塞化疗治疗。介入诊疗科现实行全年365天开放24小时绿色通道来为患者服务。介入诊疗科开展的主动脉夹层腔内治疗不但数量多而且还开展了许多新技术，如“两段式”支架植入技术，烟囱技术和复合治疗技术等。短瘤径腹主动脉瘤腔内治疗，主动脉缩窄并发症腔内治疗都取得了好成绩，改良方式房间隔封堵技术有效避免了冠状动脉栓塞。科室连续3年科室年平均完成各类大血管疾病腔内治疗300余例，先天性心脏病介入治疗100余例，其他外周介入治疗近百例。其中主动脉疾病的腔内治疗完成例数及治疗效果均位居于全世界同类单中心的前列。

The Department of Intervention of Beijing Anzhen Hospital Affiliated to Capital Medical University was duly founded on April 1, 2013. The predecessor of the department was the Catheterization Room of Anzhen Hospital, which, established in 1984, was one of the earliest catheterization rooms and has finished most cardiovascular interventional diagnosis and treatment in China. Now, the department has 8 doctors, 32 nurses and 15 medical technicians, among which are 2 chief physicians and associate chief physicians respectively. 20 of staff members have professional titles of intermediate grade and above. The department has 2 doctors, 2 masters, and over 20 of bachelor degree background. Now the department is equipped with three catheter areas, 12 large-scale angiography machines, 4 intravascular ultrasound machines (IVUS), 2 optical coherence tomography imaging systems (OCT), and 2 fractional flow reserve (FFR). Our department provides platforms of cardio angiography and interventional treatment for entire hospital, and conducts such examinations and treatments independently and collaboratively with other departments.

Adhering to the aim of a comprehensive hospital with strong professions, our department focuses on interventional treatment of cardiovascular disease and gives consideration to the same treatment of non-cardiovascular diseases. At present, apart from carrying out all various examinations of cardiovascular diseases, the interventional treatment of adult congenital heart disease is emphasized, including atrial septal defect occlusion, patent ductusarteriosus occlusion, ventricular septal defect occlusion, etc.; the interventional therapy of valvular heart diseases includes aortic stenosis balloon angioplasty, pulmonary stenosis balloon angioplasty and mitral stenosis balloon angioplasty; The intervention therapy of aorta and peripheral vessels includes aortic dissection, intramural hematoma, ulceration, endovascular repair of aorto-arteritis, pseudo aneurysm of aorta, thoracic and abdominal aortic aneurysm: surgical treatment for complex thoracoabdominal aortic aneurysm; the therapy also covers the embolotherapy for respiratory system, alimentary tract and gynecological haemorrhage, malignant tumor chemotherapy and trans arterial chemoembolization. The patient service via green channel of our department is accessible 24 hours a day, 365 days a year. The intracavitary therapy for aortic dissection is adopted by our department numerously with various new technologies have been launched, including the double-segment stent implantation, chimney technique and composite treatment. The intracavitary therapies for abdominal aortic aneurysm in short neck and aortic coarctation complication have both achieved excellent results. The improved occlusion of atrial septum may effectively avoid coronary embolism. Our department has completed over 300 intracavitary treatments of macro vascular diseases, over 100 interventional treatments of CHD and dozens of other peripheral interventional treatments annually in 3 sequent years, among which the case number and therapeutic effect for aortic disease treatments have ranked top among the same kind of single-centers in the world.

介入诊疗科承担着多项重大科研课题研究，包括完成的、在研的国家自然科学基金、北京自然科学基金、首都发展科学基金等。已获得国家新型实用技术专利3项，国家技术发明专利2项。培养了大批国内外进修学习的医务人员及承担着首都医科大学临床医学教学任务。

Our department is undertaking several major scientific research tasks, including NSFC, Beijing Natural Science Foundation, Science Foundation for Capital Development, etc. both accomplished and under study. We have obtained three patents for national utility models and two for national technological inventions, brought up a large amount of domestic and foreign medical staff by means of advanced study, and assumed pedagogical tasks of clinical medical teaching in Capital Medical University.